ANASTASIA BEEZLEY: Open Payments
NPI 1518275668 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 20 payments from 13 companies in 2025. Trend: 2023 $1,528 · 2024 $153 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $187 |
| Medtronic, Inc. | 2 | $78 |
| Tempus AI, Inc | 1 | $75 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $45 |
| Boston Scientific Corporation | 1 | $38 |
| Ferring Pharmaceuticals Inc. | 1 | $33 |
| Teleflex LLC | 1 | $31 |
| TOLMAR, INC. | 1 | $28 |
| Antares Pharma, Inc. | 1 | $25 |
| COLOPLAST CORP | 1 | $24 |
Products named: RYBREVANT, ERLEADA, INTERSTIM, XT CDX, Nubeqa, LithoVue, ADSTILADRIN, BARRIGEL.
Industry payments across MO — which companies pay providers there.
